Initial reduction of the primary tumor or lymph nodes: which is the better prognostic factor in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemotherapy followed by surgery?
Both ITR-PT and ITR-LN are promising predictors of survival in patients with ESCC who underwent NAC-DCF plus surgery. ITR-PT may be a stronger prognostic factor than ITR-LN.
Authors
- Osamu Shiraishi (ORCID: https://orcid.org/0000-0002-4740-5422)
- Atsushi Yamada (ORCID: https://orcid.org/0000-0003-3694-4153)
- Takushi Yasuda (ORCID: https://orcid.org/0000-0003-4025-8113)
- Masayuki Shinkai (ORCID: https://orcid.org/0000-0003-4102-0799)
- Takaomi Hagi (ORCID: https://orcid.org/0000-0002-4028-2714)
- Motohiro Imano (ORCID: https://orcid.org/0000-0003-2242-4245)
- Yoko Hiraki
- Tomoya Nakanishi
- Hiroaki Kato (ORCID: https://orcid.org/0000-0003-1266-4069)
- Atsushi Yasuda (ORCID: https://orcid.org/0000-0001-6708-290X)
- Masuhiro Terada
- Masashi Kohda
Institutions
- Kindai University (JP)
Publication Details
- Journal
- Esophagus
- Published
- 2025-04-28
- DOI
- https://doi.org/10.1007/s10388-025-01128-5
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01